Ceftobiprole for Staphylococcus aureus Bacteremia. Reply
N Engl J Med
.
2023 Dec 28;389(26):2498-2499.
doi: 10.1056/NEJMc2312883.
Authors
Thomas L Holland
1
,
Marc Engelhardt
2
,
Vance G Fowler Jr
3
Affiliations
1
Duke University, Durham, NC thomas.holland@duke.edu.
2
Basilea Pharmaceutica International, Allschwil, Switzerland.
3
Duke University, Durham, NC.
PMID:
38157515
DOI:
10.1056/NEJMc2312883
No abstract available
Publication types
Letter
Comment
MeSH terms
Bacteremia* / drug therapy
Cephalosporins / pharmacology
Cephalosporins / therapeutic use
Humans
Staphylococcal Infections* / drug therapy
Staphylococcus aureus
Substances
ceftobiprole
Cephalosporins